Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

February 7, 2024

https://www.globenewswire.com/news-release/2024/02/07/2825170/0/en/Terns-Pharmaceuticals-Appoints-Amy-Burroughs-as-Chief-Executive-Officer.html

FOSTER CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the appointment of Amy Burroughs as chief executive officer (CEO), effective immediately. Ms. Burroughs will also join the Terns board of directors.

Read more at globenewswire.com

Related news for (TERN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.